Raymond James Financial Services Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $69.7K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $204K | Sell |
|
|||||
|
2023
Q2 | $271K | Buy |
|
|||||
|
2023
Q1 | $274K | Sell |
|
|||||
|
2022
Q4 | $297K | Buy |
|
|||||
|
2022
Q3 | $312K | Buy |
|
|||||
|
2022
Q2 | $278K | Buy |
|
|||||
|
2022
Q1 | $317K | Buy |
|
|||||
|
2021
Q4 | $420K | Buy |
|
|||||
|
2021
Q3 | $417K | Sell |
|
|||||
|
2021
Q2 | $1.34M | Buy |
|
|||||
|
2021
Q1 | $836K | Sell |
|
|||||
|
2020
Q4 | $337K | Buy |
|
|||||
|
2020
Q3 | $216K | Buy |
|
|||||
|
2020
Q2 | $179K | Sell |
|
|||||
|
2020
Q1 | $124K | Buy |
|
|||||
|
2019
Q4 | $50K | Hold |
|
|||||
|
2019
Q3 | $61K | Sell |
|
|||||
|
2019
Q2 | $70K | Buy |
|
|||||
|
2019
Q1 | $47K | Hold |
|
|||||
|
2018
Q4 | $24K | Hold |
|
|||||
|
2018
Q3 | $42K | Buy |
|